The University of Notre Dame Australia

ResearchOnline@ND
Medical Papers and Journal Articles

School of Medicine

2015

Diagnosis and management of respiratory adverse events in the operating
room
Adrian Regli
The University of Notre Dame Australia, Adrian.Regli@nd.edu.au

Britta S. von Ungern-Sternberg

Follow this and additional works at: https://researchonline.nd.edu.au/med_article
Part of the Medicine and Health Sciences Commons
This non-refereed article was originally published as:
Regli, A., & von Ungern-Sternberg, B. S. (2015). Diagnosis and management of respiratory adverse events in the operating room.
Current Anesthesiology Reports, 5 (2), 156-167.
Original non-refereed article available here:
10.1007/s40140-015-0103-z

This non-refereed article is posted on ResearchOnline@ND at
https://researchonline.nd.edu.au/med_article/1012. For more
information, please contact researchonline@nd.edu.au.

This is the peer reviewed version of the following article:
Regli, A., and von Ungern-Sternberg, B.S. (2015) Diagnosis and management of respiratory
adverse events in the operating room. Current Anesthesiology Reports, 5(2), 156-167. doi:
10.1007/s40140-015-0103-z
The final publication is available at Springer via https://doi.org/10.1007/s40140-015-0103-z

Diagnosis and management of respiratory adverse events in the operating
room
Adrian Regli,1, 2, 3, 4 Britta S von Ungern-Sternberg5, 6
1

Consultant, Intensive Care Unit, Fiona Stanley Hospital, 102-118 Murdoch

Drive, Murdoch WA 6150 Perth, Australia
2

Consultant, Intensive Care Unit, Fremantle Hospital, Alma Street, Fremantle

WA 6959 Perth, Australia
3

Clinical Associate Professor, School of Medicine and Pharmacology, The

University of Western Australia, 35 Sterling Highway, Crawley WA 6009 Perth,
Australia
4

Associate Professor, School of Medicine, The Notre Dame University, 38 Henry

Street, Fremantle WA 6959, Australia
5

Consultant, Department of Anaesthesia and Pain Management, Princess

Margaret Hospital for Children, Perth, Australia
6

Chair of Paediatric Anaesthesia, School of Medicine and Pharmacology, The

University of Western Australia, 35 Sterling Highway, Crawley WA 6009 Perth,
Australia

Corresponding author
Prof. Britta S von Ungern-Sternberg
Chair of Paediatric Anaesthesia
Princess Margaret Hospital for Children, Perth, Australia
Britta.regli-vonungern@health.wa.gov.au

Keywords
Respiratory adverse events, respiratory complications, laryngospasm,
bronchospasm, pediatric anesthesia, stridor, desaturation, apnea, obstructive

sleep apnea, asthma, outcome, perioperative, anesthesia, treatment,
premedication, critical incident, treatment, prevention, child, upper airway
obstruction, expiration reflex, coughing, cardiac arrest

Abstract
Perioperative respiratory adverse events cause more than three quarters of all
perioperative critical incidents in pediatric anesthesia and approximately half of
anesthesia-related cardiac arrests. We can define seven main clinical types of
perioperative respiratory adverse events: upper airway obstruction,
laryngospasm, bronchospasm, severe persistent cough, apnea, stridor, and
oxygen desaturation. Depending on the definitions used for preoperative
respiratory adverse events and the cohort of children examined, the incidence
varies between 8% and 21%.
This review discusses the recognition and treatment of perioperative respiratory
adverse events. Furthermore, it provides guidance on how to identify children
who are at increased risk for developing perioperative respiratory adverse events
and how to tailor the perioperative anesthetic management for the individual child
in order to minimize the risk of perioperative respiratory adverse events.

Introduction
PRAE
Perioperative respiratory adverse events (PRAE) cause not only more than
three-quarters of all perioperative critical incidents in pediatric anesthesia [1, 2],
they also cause 30-70% of all anesthesia related cardiac arrests [3-5], three

quarter of all unplanned postoperative admissions to the pediatric intensive care
unit [6] as well as approximately half of all pediatric anesthesia-related
malpractice claims [7].

Aim and scope of review
This review discusses the recognition and treatment of PRAE. Furthermore, it
provides guidance on how to identify children who are at increased risk for
developing PRAE and how to tailor the perioperative anesthetic management for
the individual child in order to minimize the risk of PRAE.

Since PRAE are a major cause of morbidity and mortality in pediatric anesthesia,
a better understanding of the perioperative prevention and management of PRAE
are important to improve the safety of children undergoing anesthesia. This
article does not discuss PRAE related to difficult airway management.
In the perioperative period, we can define seven main clinical types of PRAE [8,
9]:

1. Partial and complete upper airway obstruction is a mechanical
obstruction to airflow that can be defined clinically as erratic respiratory
efforts in combination with an inspiratory stridor, a snoring noise or
paradoxical movement of the abdomen [10, 11]. Partial or complete upper
airway obstruction is generally reversed by the use of airway maneuvers
(e.g. chin lift, jaw thrust).
2. Laryngospasm is a partial or complete airway obstruction at the level of the
larynx. A clinical definition of a laryngospasm is either absent airflow or

inspiratory stridor coupled with muscle rigidity of the abdominal and chest
walls during increased inspiratory effort. Associated clinical signs may
include cough, expiration reflex, breathholding and straining during
inspiration and expiration as part of the laryngeal reflex responses to
laryngeal stimulation.
3. Bronchospasm is a severe narrowing of the distal airways and can be
defined as an increased respiratory effort, particularly during expiration, and
wheeze on auscultation or silent chest with minimal chest movement in
severe cases. Associated clinical signs may include cough, straining during
inspiration and expiration, use of accessory muscle, as well as tracheal and
chest wall tugging.
4. A severe persistent cough is defined as a series of pronounced, persistent
severe coughs lasting for > 10 seconds in duration. A severe cough might be
associated with a laryngospasm (see above).
5. Apnea is defined as complete cessation of gas flow for > 10 seconds
irrespective of the presence or absence of inspiratory efforts (varying
definitions) or less if the apnea is associated with bradycardia, cyanosis or
pallor.
6. Stridor is defined as an abnormal, high-pitched breathing sound mainly on
inspiration that is produced by increased turbulent airflow through a partially
obstructed airway.
7. Oxygen desaturation has a range of definitions in the perioperative period
that span from < 90-95%. In many institutions, 95% is the cut-off value for
discharge to the patient ward and is thus the most commonly used definition
of perioperative oxygen desaturation in an otherwise healthy child. Oxygen
desaturation is often caused by the occurrence of other PRAE (e.g.
laryngospasm), with the latter the goal of the intervention to restore the
oxygen saturation.

Epidemiology
Depending on the definitions used for PRAE and the cohort of children
examined, the incidence of PRAE varies between 8% and 21% [8, 12, 13]. In the

largest observational trial reported to date, the incidence of PRAE in children was
approximately 15% [8], with oxygen desaturation reported in 10%, coughing in

7%, upper airway obstruction in 4%, laryngospasm in 4%, bronchospasm in 2%,
and stridor in 1% [8]. The patient-related risk factors associated with PRAE are

summarized in Table 1 [1, 2, 8, 13-22].

Upper airway obstruction
Epidemiology
For the purpose of this review, upper airway obstruction (supra-glottic airway
obstruction) is defined as mechanical non–reflex mediated airway obstruction.
Most anesthetic agents cause a dose-dependent reduction in pharyngeal
muscles tone thereby increasing the degree of upper airway obstruction. As a
result of the relative benign nature of upper airway obstruction in the hands of
skilled anesthetists, their occurrence is often underreported or not reported at all
[1, 12, 15, 17]. The incidence of mechanical upper airway obstruction has been
reported between 3.6 and 9.1% [8, 13]. However, failure to maintain a patent

airway due to the lack of skill in the operator or in observation may rapidly result
in hypoxemia, bradycardia or even cardiac arrest [4, 5, 23]. Therefore, airway

maneuvers that restore airway patency belong to the core clinical skills of every
anesthetist.

Upper airway obstruction is particularly common in children with obstructive sleep
apnea [24]. Obstructive sleep apnea occurs in approximately 10% of the school-

age children [25]. Symptoms range from mild snoring to obstructive sleep apnea
syndrome with episodic apneas and desaturations.

Causes
The upper airway, which is mainly composed of soft tissues, maintains its
patency during inspiration by the outward action of the pharyngeal airway
muscles. Children are particularly susceptible to upper airway obstruction
because the dimensions of their airways are smaller, thus increasing the
resistance to airflow.

Most anesthetic agents reduce muscle activity in a dose-dependent manner,
thereby reducing the patency of the airway also in a dose-dependent manner [10,
26-29]. In contrast to common belief that general anesthesia causes a

predominant reduction in genioglossus muscle activity with the tongue being the
main site of obstruction, the soft palate and the epiglottis are more frequently the
site of perioperative upper airway obstruction in children [30-37].
Upper airway obstruction can be caused by anatomical abnormalities (e.g.
tonsillar or adenoidal hypertrophy) or a reduction in upper airway muscle tone
(e.g. anesthetic agents). In children with OSAS, tonsillar and adenoidal
hypertrophy reduce the volume of the upper airway [25, 38]; commonly the soft

tissue is thickened due to larger retropharygneal nodes [39, 39]. There is an age
related maximum increase in the bulk of the oropharyngeal soft tissue

(particularly tonsils and adenoids) in relation to the bone structures with the
upper airway being smallest at the age of four years [40].
Diagnosis
Clinical signs of a perioperative upper airway obstruction range from snoring and
inspiratory stridor to paradoxical movements of the abdomen and absent airflow
during partial and total upper airway obstruction, respectively [10, 11, 29].

Treatment
Airway maneuvers generally reverse upper airway obstruction by increasing
glottic opening [10, 11]. Both chin and jaw thrust effectively increase the cross

sectional area in the pharynx. Chin lift increases the antero-posterior dimensions
at all pharyngeal levels with predominance at level of the epiglottis [41]. Neck

flexion (chin to chest) decreases whereas neck extension in general increases
the dimensions of the pharyngeal space, the latter attenuating the resistance to
inspiration and therefore the severity of upper airway obstruction [26]. Turning
the head to the side however has only a small influence on upper airway

dimensions [26]. Positioning the child in the lateral decubitus position reduces
airway obstruction and substantially enhances the effectiveness airway

maneuvers [42]. A neck collar to prevent downward displacement of the

mandible and maintaining slight neck extension increases cross sectional area at
the level of epiglottis and tongue and can be used during MRI [43]. Alternately,

upper airway patency can be preserved in most infants and children during MRI
by simply placing a roll under the shoulders or cervical spine to extend the neck
[44].

CPAP is defined as continuous positive airway pressure. It provides continuous
positive pressure in the upper airway throughout all phases of the respiratory
cycle. This positive pressure offsets in part, the negative pressure created during
maximum inspirational effort, thereby increasing the cross sectional area of the
pharynx [29]. Pressures as little as 5 cmH 2 O can be sufficient to overcome

sedation related upper airway obstruction but greater pressures may be required
in children with tonsillar or adenoid hyperplasia [29]. This so called airway
splinting is useful not only in children with OSAS but also in those with
anesthesia-related upper airway obstruction [10, 29, 36].

Laryngospasm
Epidemiology
The incidence of perioperative laryngospasm varies widely in the literature from
0.1 to 16%, primarily due to differences in its definition [20, 45]. While

perioperative laryngospasm occurs in approximately 4% of children in a general
pediatric population [8, 13], smaller frequencies have been reported in

retrospective studies or when only severe forms have been reported (e.g.
laryngospasm triggering a “call for help”) [1, 2, 17, 45-47], whereas greater

frequencies have been reported in children with associated risk factors (Table 1).

Laryngospasm occurs most frequently during emergence from anesthesia, and
next most commonly during induction of anesthesia. Laryngospasm is infrequent
during maintenance and in the post-anesthesia care unit (0.1 to 0.4%) [8, 13, 17-

19, 45, 46, 48]. Laryngospasm is not only the most frequent respiratory cause of

perioperative cardiac arrest in children [4], but it is also responsible for half of the

perioperative “call for help” emergencies [47]. If left untreated, laryngospasm can

rapidly lead to hypoxemia, bradycardia and cardiac arrest or in older children and
adolescents, to negative pressure pulmonary edema, the need for ongoing
mechanical ventilation and intensive care admission [49, 50].
Causes
There are two main causes for perioperative laryngospasm: imprimis, a lack of
inhibition of glottic reflexes due to inadequate central nervous system depression
and, secondly, an increased mechanical stimuli in the airway [51]. The causes of
mechanical stimulation at an inappropriate depth of anesthesia include the

presence of a tracheal tube, particularly at the time of intubation or extubation,
secretions, gastric fluid or blood irritating the vocal cords, or stimulation of the
airway by an artificial airway device, laryngoscope or suction catheter [51].
Although clinical experience suggests that laryngeal reflexes are more

pronounced during lighter levels of anesthesia, the literature describes similar
incidences after direct laryngeal stimulation (except for the expiration reflex) at
different levels of sevoflurane anesthesia [9, 52, 53]. However, the time to return

to normal breathing during deeper levels of anesthesia is less than during lighter
levels of anesthesia [9]. Therefore, the common practice to deepen anesthesia in

case of a laryngospasm and other respiratory reflex responses remains
warranted. Risk factors for laryngospasm are summarized in Table 1.

Pathophysiology
Simulation of the superior laryngeal nerve in response to stimulation of the
supraglottic tissue and especially the vocal cords can trigger a reflex innervation
of the intrinsic laryngeal muscle via the recurrent laryngeal nerve leading to
laryngeal reflex responses including laryngospasm (closure of vocal cords and/or
false cords), cough, expiration reflex (cough without preceding inspiration) and
apnea (cessation of airflow > 10s) [9, 52, 54-56]. Apnea can occur in combination
with a prolonged laryngospasm or alone. Interestingly, the incidence of laryngeal

reflex responses decreases the more distal within the respiratory tract a stimulus
occurs [52].
Laryngospasm has been subdivided into partial and complete airway obstruction
[57]. Contraction of the adductor muscles (intrinsic laryngeal muscles) often

causes incomplete vocal cord closure (“shutter mechanism”) [57] resulting in

limited gas flow across the vocal cords, and possibly stridor. Contraction of the
thyrohyoid muscle, sternohyoid muscle, sternothyroid muscle (extrinsic laryngeal
muscles) causes an upward movement of the larynx relative to the hyoid bone.
Concurrently, excessive laryngeal tissue folds including the paraglottis and false
cords resulting in complete glottic closure (“ball valve mechanism”) [57]. In the
latter scenario, gas flow ceases and stridor is inaudible. Video analysis of

laryngeal stimulation confirms glottic closure during cough, expiration reflex and

laryngospasm occurs predominantly at the level of the false cords [9, 54, 55].
Diagnosis
Laryngospasm is a form of acquired upper airway obstruction. For the trainee
anesthetist or the occasional pediatric anesthetist, classic upper (supraglottic)
airway obstruction and laryngospasm are often difficult to differentiate [58].

Airway maneuvers are immediately effective in treating upper airway obstruction
and in many cases can also relieve laryngospasm [9, 51, 55, 56, 59].
An inspiratory stridor is usually audible during partial laryngospasm [51],

whereas stridor is absent during complete laryngospasm [56]. Laryngospasm

might be preceded by an expiration reflex that can be coupled with an “expiratory
stridor” [57]. Depending on the degree of airway obstruction, paradoxical chest
movements, intercostal recessions and tracheal tug are often present [51, 56].

Some clinicians insist that the only “true” laryngospasm is complete

laryngospasm [50]. However, both partial and complete laryngospasm are
associated with increased morbidity. When managing a pediatric airway

emergency, it is more important to actually treat laryngospasm than to engage in
a discourse about the academic subtyping of the laryngospasm [51].
Treatment
Laryngospasm is a time-dependent, critical event that requires immediate
treatment. It is important to minimize or eliminate the cause of the airway
stimulation and to rapidly deepen anesthesia (e.g. propofol 0.5-0.8 mg/kg IV) [56,

60-62]. At the same time, airway maneuvers should be performed (e.g. jaw
thrust) and the inspired oxygen concentration increased to 100% [51, 56].

Jaw thrust has the potential to convert a total into a partial or no laryngospasm by
lengthening the laryngo-hyoid distance thereby reducing the “ball-valve” effect
[56, 57]. In addition to subluxing the temperomandibular joint and opening the

mouth, applying the jaw thrust to the coronoid process at the ascending ramus of
the mandible causes intense pain [63]. This elicits a “fright and flight” response,
which includes vocalization, a maneuver that opens the vocal cords. This alone
may break a partial laryngospasm.
During partial laryngospasm CPAP alone may be sufficient to overcome the
increased airway resistance caused by the glottis narrowing [51, 56]. However in
the presence of a complete laryngospasm, CPAP may increase the pressure of
the false cords onto the vocal cords (ball valve effect, see above), insufflate the
stomach and cause respiratory aspiration of gastric content [56, 57]. It is

therefore advisable to perform airway maneuvers before the application of CPAP.
In case of severe desaturation without response to the initial steps,
succinylcholine 1–2 mg/kg ± IV atropine (10-20 mcg/kg) should be given without
delay. An early bail out is vital to avoid catastrophic outcomes of laryngospasm
[9, 51, 56].
In the absence of IV access, intralingual (submental approach) or intramuscular
succinylcholine can be applied 3-4 mg/kg [64]. Interestingly, only around 50% of

children given a NMBA to treat laryngospasm will require endotracheal intubation
[45].

Prevention
Education
The incidence of perioperative laryngospasm in infants and children can be
reduced by education and training with regards to the prevention, recognition and
treatment of a laryngospasm [51]. The introduction of an education package for
staff halved the incidence of laryngospasm that resulted in “a call for help” [47].

Ensuring availability of emergency drugs such as propofol, succinylcholine and
atropine at all times is strongly recommended [47].
Airway device
Despite published findings that the use of LMA was associated with a greater risk
of laryngospasm than ETT [12, 15, 19, 45, 47], a large observational trial found

that the incidence of laryngospasm after an ETT was associated with double the
rate of laryngospasm (6%) when compared with that after using LMA (3%) in
children [8, 18]. This latter finding is consistent with a recent meta-analysis that

also reported a reduced incidence of laryngospasm with LMAs as compared with
ETTs [65]. The explanation for these inconsistent findings might be selection

bias or different techniques involved when using ETT or LMA [12, 15, 19, 45, 47].
Amongst other factors, inadequate anesthetic depth whilst inserting and

removing an LMA, multiple attempts at intubation, intubation by a trainee as
compared with a consultant have been identified as factors increasing the
incidence of laryngospasm [8, 18].
With regards to the frequency of laryngospasm or bronchospasm, there was no
difference found in an RCT when comparing deep vs awake ETT removal in
children undergoing adenotonsillectomy [66]. However, the frequencies of severe
coughing and postoperative hoarse voice were greater in children whose airways
were extubated awake. There was also a trend towards more frequent and
prolonged hemoglobin desaturations. In contrast, the frequency of airway
obstruction (not associated with desaturation) was more common after deep
tracheal extubation [66]. Of all airway management options, the use of a face

mask was associated with the smallest frequency of laryngospasm [8, 12, 18].

Anesthetic agents
While premedication with midazolam does not appear to influence the
occurrence of laryngospasm [8, 18], it is associated with a 1.8 fold increase in
overall PRAE. Against common belief, the incidence of laryngeal reflex

responses to direct laryngeal stimulation (except for the expiration reflex) is not
influenced by the depth of anesthesia [9, 52, 53]. However, the time to return to a
normal breathing pattern during a deeper level of anesthesia is less than after a
lighter level of anesthesia [9], supporting the common practice to deepen
anesthesia in case of laryngeal reflex responses.

To reduce the risk of laryngospasm, an IV induction is preferred instead of an
inhalational induction [8, 9, 45, 67]. While NMBA can reduce the risk of

laryngospasm at the time of tracheal intubation [68], a large observational cohort
study demonstrated a greater incidence of laryngospasm in the postoperative

period [8]. Maintenance of anesthesia with sevoflurane, propofol or isoflurane is

associated with a significantly smaller incidence of laryngospasm compared with
desflurane, which should be avoided in children (see also under bronchospasm)
[8, 69].

The role of opioids to prevent laryngospasm remains controversial [54, 70].

However, remifentanyl is increasingly used to suppress laryngeal and bronchial
reflex constriction during airway manipulations [71].
Lignocaine
IV lignocaine reduces the frequency of laryngospasm [55, 72]. Whether it is

applied topically by spraying the vocal cords either blindly or under direct vision
before placing the ETT, this role of lignocaine remains controversial since some
studies reported the frequency of laryngospasm actually increased when
lignocaine was used for intubation without muscle relaxants [8, 73].

Other agents
Magnesium (15 mg/kg magnesium IV in 30 ml NaCL 0.9% over 20 min) may be
used to prevent laryngospasm after adeno-tonsillectomy [74, 75]. Preoperative

salbutamol either via metered dose inhaler or via nebulizer (2.5 mg if weight <20
kg, 5 mg if weight >20 kg) 10–30 min prior to surgery may reduce the risk of
laryngospasm and bronchospasm in patients with recent upper respiratory tract
infection [20].
Bronchospasm
Epidemiology
While the incidence of perioperative bronchospasm in the general pediatric
population is 0.2-4.1% [1, 8, 13, 46, 76], it is 2.2-5.7% in children with asthma.

Generally, perioperative bronchospasm has a benign outcome although some
episodes may warrant admission to PICU (3.8% of children with bronchospasm)
or cardiac arrest (in 1-2.4%) [4, 5, 8, 76].
Causes
There are three major triggers for perioperative bronchospasm [77]:

1) Mechanical: Airway manipulation (e.g. tracheal intubation) can stimulate
tracheal and laryngeal sensory nerves with efferent activation of the vagus nerve
(para-sympathetic acetylcholine binding the M3 muscarinic receptors) leading to
a bronchoconstriction.
2) Anaphylactoid reaction (non-immunological): Medications (e.g. morphine) can
directly degranulate mast cell and basophils with subsequent histamine release
and binding to histamine receptors leading to bronchoconstriction.
3) Immunological-anaphylaxis: Medications or other external stimuli can cause
an immune mediated (immunoglobulin E) degranulation of mast cells and
basophils with subsequent bronchoconstriction as described above.

The airway response to any of the above triggers can vary between
subclinical mildly increased bronchial smooth muscle tone and a severe life
threating bronchospasm and anaphylactic shock if immune mediated.
However, the most common trigger for perioperative bronchospasm appears
to be mechanical [76]. Indeed, perioperative bronchospasm occurs mainly

during induction and emergence when mechanical stimulation of the airway is
greatest [12].
Risk factors
Numerous risk factors for perioperative bronchospasm have been identified
(Table 1). In general, airway inflammation causes airway susceptibility thereby
increasing the risk of bronchospasm or laryngospasm following airway
manipulation. Importantly, acute and chronic airway inflammation and can persist
beyond the presence of respiratory symptoms. Of note: While an acute asthma
exacerbation increases the risk for perioperative bronchospasm, a perioperative
bronchospasm is unlikely to progress to an asthma exacerbation.

Diagnosis
Bronchospasm can be described as a sudden increase in bronchial smooth
muscle tone associated with increased airflow obstruction often of short
duration. Clinical signs include increased respiratory effort, particularly during
expiration, and wheeze on auscultation. In severe cases the patient may have
minimal chest movement with silent chest on auscultation. Additionally slow or
incomplete expiration on inspection, oxygen desaturation, a prolonged phase
2 as well as an increased slope of phase 3 on the capnogram, high airway
pressures and delayed expiratory flow on the flow-time curve may be noticed.
If the bronchospasm is secondary to an anaphylactic or anaphylactoid
reaction then rash, urticarial, angioedema, hypotension and tachycardia can
be present [78].

Endobronchial intubation, pneumothorax, pulmonary edema, kinked or
obstructed endotracheal tube can mimic a bronchospasm and need to be
excluded.

Treatment of bronchospasm
As in the case of laryngospasm, treating an episode of perioperative
bronchospasm should aim primarily to reduce any further stimuli and if possible,
deepen the level of anesthesia followed by the administration of 100% oxygen. IV
propofol or preferably volatile anesthetic agents are excellent bronchodilators
that have been used to treat severe exacerbations of asthma (see below).

Beta-2 agonists should be considered. Importantly, compared with the doses
used in awake children, the doses required to achieve a clinical response in
children with intubated airways are more than 10 fold greater as less than 3% of
the dose reaches the bronchial site of action [79, 80]. Recent evidence suggests
that variability in the response to beta-2 agonists in some children may be
explained by four single nucleotide polymorphisms within the glutathionedependent S-nitrosoglutathione reductase, adrenergic receptor beta-2 and

carbamoyl phosphate synthetase-1 [81]. Future treatments may be adjusted

based on these polymorphisms, to ensure successful goal-directed therapies.

If severe airflow obstruction persists, beta-2 agonists may also be given as a
continuous infusion e.g. salbutamol 15 mcg/kg bolus over 10 min followed by 1 to
5 mcg/kg/min [82, 83]. In addition, anticholinergics including atropine 20 mcg/kg,
glycopyrolate 20-40 mcg/kg and/or IV magnesium sulfate [84] may provide
further bronchodilation.

Glucocorticosteriods should be considered if the bronchospasm is severe and
persistent, especially when the bronchospasm may be the result of bronchial
hyperreactivity or asthma. Inhaled or oral steroids are the main pillar of asthma
treatment as they can reliably reduce airway inflammation and therefore reduce
bronchial edema, bronchial mucus production and reduce the bronchial smooth
muscle tone.

Ventilation of the lungs in children with a bronchospasm should follow the
principles of protective lung ventilation for patients with severe airflow limitation
(e.g. asthma exacerbation). The main principle is to minimize the risk of
hyperinflation and barotrauma. A small respiratory rate, with a greater expiratory
time and a decreased inspiratory to expiratory ratio (I:E ratio) should be applied
whilst accepting “permissive hypercapnia”. At physiological lung conditions,
plateau pressure should be limited since they are similar to alveolar pressures
and are closely associated with the incidence of barotrauma. However, in the
presence of airflow obstruction (e.g. in asthmatic children), plateau pressures
and even more so peak inspiratory pressures do not reliably reflect alveolar
pressures and higher airway pressures can be accepted without the risk of
barotrauma. Flow-time curves can aid to monitor whether expiratory flows return
to baseline [85, 86].

In children who develop a perioperative bronchospasm, a trial of high flow
humidified oxygen or noninvasive ventilation might be beneficial in the post
anesthetic care unit, not only to improve oxygenation but also to reduce the work
of breathing. Noninvasive ventilation is feasible in children with asthma
exacerbations and may have a role in children with prolonged perioperative
bronchospasm. When using noninvasive ventilation, PEEP is ideally set below
auto-PEEP (around 5 cmH 2 O), whilst for inspiratory pressures, 10 and 15
cmH 2 O are typically required [87].
Bronchospasm prevention

Premedication
Premedication with beta-2 agonists is recommended for all children with
moderate or severe asthma or in those who are actively wheezing due to reactive
airway disease (e.g. upper respiratory tract infection) in order to reduce the risk
of PRAE [20, 88, 89].
Even though benzodiazepines might be useful to reduce preoperative anxiety,
benzodiazepines do not reduce the incidence of perioperative laryngospasm or
bronchospasm but instead may increase desaturations and upper airway
obstructions particularly in children with an increased risk for PRAE [8]. Despite
reflex bronchoconstriction blunting properties the role alpha-agonists as a
premedication remains unclear [77, 90-93].
Lignocaine
In adult asthmatic volunteers, inhaled and IV lignocaine blunts bronchoconstrictive effects of histamine and acetylcholine (but not metacholine) as well
as of airway manipulation [94-98]. However, caution should be used since IV

lignocaine can decrease airway diameter [99] and cause bronchospasm [100].
Airway manipulation

In general, less invasive airway devices and less airway manipulation reduce the
risk of PRAE (see also under laryngospasm) [8]. If a child needs an ETT, we

recommend the use of a cuffed as opposed to an uncuffed ETT in children with
airway susceptibility especially to allow the application of greater peak airway
pressures during mechanical ventilation [101]. A further advantage irrespective

of the presence of airflow obstruction is that cuffed ETTs are associated with less
postoperative sore throat [102].
Anesthetic agents
All volatile and most IV anesthetic agents are direct bronchodilators under
physiological conditions [77]. In general, volatile anesthetic agents only have a

limited ability to blunt reflex bronchoconstriction but exhibit good bronchodilatory
effects, whereas propofol IV has particularly good ability to blunt reflex
bronchoconstriction but a reduced bronchodilatatory effect [8, 103, 104], making
propofol IV the induction agent of choice in children with increased risk of
developing PRAE.

Compared with other volatile anesthetic agents, desflurane is associated with an
increased bronchial smooth muscle tone and airway resistance, especially in
children with increased airway susceptibility and should therefore be avoided [8,
69, 77, 105, 106].

In comparison with thiopental and etomidate, propofol is associated with least
airway resistance after tracheal intubation [107]. Thiopental is better avoided in

children with asthma due to its increased risk of causing bronchospasm on
induction (probably via non-immunological anaphylaxis) [108, 109].

Although ketamine can blunt airway reflexes and has direct bronchodilatory
properties [108], it has an inferior bronchodilatory effect in comparison to volatile
anesthetic agents. Additionally, there is no outcome benefit in addition to

standard treatment in children with asthma exacerbation giving ketamine only a

limited role in treating perioperative bronchospasm [110, 111]. Additionally,

ketamine has not been shown to be superior to propofol as an induction agent
and is associated with other adverse events in the postoperative period, e.g. a
greater frequency of PONV, greater recovery times and hallucinations.

Neuromuscular blocking agents
If bronchospasm is persistent and severe, NMBA are recommended in the initial
phase in order to improve mechanical ventilation [85, 112]. However, caution
must be taken as NMBA can aggravate airflow obstruction via histamine

liberation [77]. The risk of causing a bronchospasm through histamine liberation

is greatest with mivacurium followed by suxamethonium, rocuronium, vecuronium
and atracurium [77, 108]. In children, vecuronium, suxamethonium, and
rocuronium have been shown to cause immunological (IgE mediated)

anaphylaxis [77]. Pancuronium however does not liberate histamine and is least
associated with immunological anaphylaxis.

Postoperative analgesia
Non-steroidal anti-inflammatory drugs (NSAIDs) increase leukotriene production
by inhibiting the cyclooxygenase. NSAIDs have been associated with causing
bronchospasm, laryngospasm, rhinorrhea, and periorbital edema especially in
children with a history of asthma and chronic rhinosinusitis and nasal polyposis.
Aspirin should be avoided in children with asthma to avoid aspirin asthma
syndrome.

However, the frequency of NSAID-induced postoperative bronchospasm is small
even in patients with asthma [113, 114]. Clinical studies in children with asthma

who are receiving NSAIDs have shown no or only minimal temporary changes in
respiratory function [115, 116]. Therefore, a short-term course of NSAIDs has a
small risk of precipitating bronchospasm in children with asthma unless they

have a history of nasal polyposis or known respiratory intolerance to NSAIDs.

Furthermore, one should also exercise caution in children with asthma when
prescribing acetaminophen (paracetamol) for postoperative pain as there is
emerging evidence of acetaminophen (paracetamol) being a causative agent of
asthma [113].
Children with asthma
In all children with asthma, preexisting oral and /or inhaled steroids should be
continued and if necessary given IV. In children with poorly controlled asthma,
surgery should ideally be delayed in order to initiate or intensify medical asthma
treatment and allow time for respiratory improvement. A short-term course of
systemic steroids is warranted should asthma symptoms be severe and
persistent or where inhaled steroid cannot be provided. When surgery cannot be
delayed, initiating or intensifying asthma treatment is recommended with inhaled
beta 2 agonists and IV steroids. Additionally, specialist referral for further ongoing
management including PICU admission for children with severe asthma
exacerbation should be considered. Children with poorly controlled asthma
should immediately be given bronchodilator therapy either via nebulizer or a
pMDI. If necessary, ipratropium bromide has an additional bronchodilatory effect
and can be given together with the beta-2-agonsist.

Oxygen Desaturation
Oxygen desaturation is more a symptom than a diagnosis as hypoxemia is the
common final result of most respiratory and some non-respiratory pathologies.
Accordingly, the differential diagnosis of perioperative hypoxemia is large. The
more frequent causes of hypoxemia include upper airway obstruction,
bronchospasm, laryngospasm, tension pneumothorax, atelectasis, aspiration or
pulmonary edema.

Apart from chest trauma or iatrogenic causes (e.g. insertion of central venous
line) tension pneumothorax can be the result of injurious bag valve mask or

mechanical ventilation in the presence of a bronchospasm or asthma
exacerbation. Asymmetrical chest movement, percussion and auscultation or
chest XR can confirm the diagnosis prior the insertion of a chest drain.
Atelectasis is frequent in children with asthma due to mucus plugging in relatively
small airway calibers. If atelectasis and hypoxia is severe the patient might
benefit of endobronchial suctioning. However, care must be taken as this process
itself can irritate airways and itself can worsen airflow obstruction.

Conclusions
In conclusion, respiratory adverse events are common in pediatric anesthesia. A
careful medical history can help to identify children at increased risk and allow
the anesthesiologist to tailor the anesthestic for the individual child. In case of
perioperative PRAE, treatment without delay is essential to avoid hypoxemia.
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